Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Department of Medical Oncology, Gustave Roussy, Villejuif, France.
B
B
Escudier
IRCCS San Matteo University Hospital Foundation, Pavia, Italy.
C
C
Porta
Department of Medicine I, Clinical Division of Oncology and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
M
M
Schmidinger
Department of Pathology, Rennes Hospital and University, Rennes, France.
N
N
Rioux-Leclercq
Division of Surgical Oncology-Urology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
A
A
Bex
Institute of Cancer Research, Royal Marsden Hospital, London, UK University of Melbourne and Monash University, Victoria, Australia.
V
V
Khoo
Clinic for Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Medical School Hanover, Hanover, Germany.
V
V
Gruenvald
The Institute of Cancer Research, London, UK.
A
A
Horwich
D002292:Carcinoma, Renal Cell / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D005500:Follow-Up Studies; D006801:Humans; D007680:Kidney Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D009367:Neoplasm Staging